CANNAPHARMARX INC | NT 10-K: Others
Mar 27 12:08 ET
CANNAPHARMARX INC | 8-K/A: Current report (Amendment)
Feb 22 07:56 ET
CANNAPHARMARX INC | 8-K: Current report
Feb 16 12:06 ET
CANNAPHARMARX INC | 8-K: Current report
Dec 6, 2023 16:01 ET
CANNAPHARMARX INC: Q3 2023 Earnings Report
Nov 17, 2023 16:05 ET
CANNAPHARMARX INC | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Nov 14, 2023 15:01 ET
CANNAPHARMARX INC | 8-K: Current report
Nov 13, 2023 13:51 ET
CANNAPHARMARX INC | 8-K: Current report
Oct 13, 2023 14:38 ET
CANNAPHARMARX INC | 10-Q: Q2 2023 Earnings Report
Oct 13, 2023 10:20 ET
CANNAPHARMARX INC | 3: Initial statement of beneficial ownership of securities-Director Panek Anthony Michael
Oct 3, 2023 14:13 ET
CANNAPHARMARX INC | 10-Q: Q1 2023 Earnings Report
Sep 22, 2023 14:51 ET
CANNAPHARMARX INC | 10-K: FY2022 Annual Report
Sep 1, 2023 13:08 ET
CANNAPHARMARX INC | 8-K: Current report
Aug 28, 2023 16:21 ET
CANNAPHARMARX INC | 8-K: Current report
Jun 23, 2023 06:00 ET
CANNAPHARMARX INC | NT 10-K: Others
Mar 30, 2023 11:25 ET
CANNAPHARMARX INC | 10-Q: Q3 2022 Earnings Report
Nov 21, 2022 16:06 ET
CANNAPHARMARX INC | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Nov 14, 2022 07:14 ET
CANNAPHARMARX INC | DEF 14A: Definitive proxy statements
Oct 3, 2022 19:33 ET
CANNAPHARMARX INC | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Aug 25, 2022 20:20 ET
CANNAPHARMARX INC | 10-Q: Q2 2022 Earnings Report
Aug 22, 2022 16:10 ET
No Data
No Data